Completed OBSERVATIONAL NCT03462524

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

Neoadjuvant Therapy for Locally Advanced Esophageal Cancer: Impact on Cardiopulmonary Physiology, Short- and Long-term Morbidity

Sponsor: St. James's Hospital, Ireland

Conditions Adenocarcinoma Chemotherapy Effect Esophageal Cancer Pneumonia Pulmonary Fibrosis Radiation Fibrosis Radiation Pneumonitis Radiation Toxicity Respiratory Failure Squamous Cell Carcinoma Surgery

Interventions Esophagectomy

Updated 6 times since 2018 Last updated: Mar 5, 2018 Started: Jan 1, 2010 Primary completion: Jan 1, 2016 Completion: Jan 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03462524, this observational or N/A phase trial focuses on Adenocarcinoma and Chemotherapy Effect and remains completed. Sponsored by St. James's Hospital, Ireland, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Mar 2018 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. James's Hospital, Ireland

Data source: St. James's Hospital, Ireland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dublin, Ireland